Previous 10 | Next 10 |
INVO Bioscience (NASDAQ:INVO) has received approval by Medical Devices Control Division for FDA Thailand to import and commercialize INVOcell in Thailand. Shares up 9.7% premarket at $3.40. In April 2021, INVO Bio inked exclusive distribution agreement with IVF Envimed Company Ltd. ...
INVO Bioscience Obtains Regulatory Approval to Commercialize INVOcell In Thailand INVO's distribution partner, IVF Envimed Company Ltd., set to begin commercialization of the INVOcell system within Thailand. PR Newswire SARASOTA, Fla. , Dec. 1, 2021 /PRNewswi...
INVO Bioscience, Inc. (INVO) Q3 2021 Earnings Conference Call November 15, 2021 4:30 PM ET Company Participants Robert Blum – Lytham Partners, LLC Steve Shum – Chief Executive Officer Mike Campbell – Chief Operating Officer and Vice President-Business Development Andrea G...
INVO BioScience (NASDAQ:INVO): Q3 GAAP EPS of -$0.24 misses by $0.04. Revenue of $0.22M (-35.3% Y/Y) misses by $0.11M. Shares +6.06%. Press Release For further details see: INVO BioScience EPS misses by $0.04, misses on revenue
INVO Bioscience Reports Third Quarter 2021 Financial and Operating Results and Provides Business Update Company to Host Conference Call Today at 4:30pm ET (Details Below) PR Newswire SARASOTA, Fla. , Nov. 15, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (N...
INVO Bioscience to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021 Financial results to be released after market close; Conference call to be conducted at 4:30 pm ET PR Newswire SARASOTA, Fla. , Nov. 9, 2021 /PRNewswire/ -- INVO Bio...
INVO Bioscience (NASDAQ:INVO) announces that it will regain full U.S. commercialization rights for its patented INVOcell device. Shares up more than 11% post market. The update follows Ferring International Center S.A.'s termination for convenience of that certain Dis...
INVO Bioscience Regains Full U.S. Commercialization Rights PR Newswire SARASOTA, Fla. , Nov. 8, 2021 /PRNewswire/ -- INVO Bioscience, Inc. ("INVO" or the "Company") (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo c...
INVO Bioscience Announces Four Individual Poster Abstracts Discussing the Benefits of INVOcell Presented at the 2021 American Society for Reproductive Medicine (ASRM) Congress & Expo INVO Bioscience Announces Four Individual Poster Abstracts Discussing the Benefits of INVOce...
INVO Bioscience Announces Grand Opening of "Positib Fertility, an INVO Center" in Monterrey, Mexico on November 1, 2021 Positib Fertility, an INVO Center, becomes first international JV-owned clinic focused on providing INVOcell to assist the underserved patients in need of adva...
News, Short Squeeze, Breakout and More Instantly...
SARASOTA, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment worldwide through the establishment and acquisition of fertility clinics, and with the intrava...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 73.2% to $0.0646 on volume of 191,555,690 shares AGBA Group Holding Limited (AGBA) rose 245.0% to $1.38 on volume of 41,065,125 shares TIAN RUIXIANG Holdings Ltd (TIRX) rose 135.2% to $1.14 on volum...
2024-04-18 06:37:00 ET Here’s the Top 3 Reasons to Trade Penny Stocks in 2024 Penny stocks represent a unique investment opportunity for those looking to diversify their portfolios with high-growth potential securities. Characterized by their low price per share, typically under ...